Pfizer Inc., USA

• The Disease of Pain and Current Market Trends;Oral Opiods;Anti-inflammatory drugs;Ion Channel Modulators;Neurotransmitters and Other Non-Opiate Central Mechanisms;Biotherapeutics for the Treatment of Pain;Peptide Therapeutics from Venomous Creatures;Non Oral Treatments for Pain;Affective and Cognitive Modulation of Pain;Pain Management Companies;Enabling Next Generation Pain Therapeutics through Precision Medicine;Case study - Discovery and Development of Pregabalin;Case Study - Discovery and Development of the Butrans Patch

"The inclusion of information on clinical trial status and typical dosages for approved drugs also make this book interesting to clinical scientists and those involved in the treatment of pain patients. Each chapter contains a thoughtful introduction and conclusion along with general pharmacology needed to understand the activity, and a discussion of some of the major areas of pharmaceutical research.""Overall, the book does a good job of consolidating a wide range of pain topics into a single easily accessible volume.""This book is a well-balanced reference manual for new entrants into pain drug discovery or a general resource for the overview of the current state of pain therapeutics for more experienced researchers.""This compilation does an excellent job of addressing the current state of the field and known targets for the development of pain therapeutics."